vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and TSS, Inc. (TSSI). Click either name above to swap in a different company.

TSS, Inc. is the larger business by last-quarter revenue ($60.9M vs $40.7M, roughly 1.5× PETMED EXPRESS INC). TSS, Inc. runs the higher net margin — 20.0% vs -26.0%, a 45.9% gap on every dollar of revenue. On growth, TSS, Inc. posted the faster year-over-year revenue change (21.8% vs -23.3%). TSS, Inc. produced more free cash flow last quarter ($15.8M vs $-9.2M). Over the past eight quarters, TSS, Inc.'s revenue compounded faster (95.8% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

PETS vs TSSI — Head-to-Head

Bigger by revenue
TSSI
TSSI
1.5× larger
TSSI
$60.9M
$40.7M
PETS
Growing faster (revenue YoY)
TSSI
TSSI
+45.0% gap
TSSI
21.8%
-23.3%
PETS
Higher net margin
TSSI
TSSI
45.9% more per $
TSSI
20.0%
-26.0%
PETS
More free cash flow
TSSI
TSSI
$25.0M more FCF
TSSI
$15.8M
$-9.2M
PETS
Faster 2-yr revenue CAGR
TSSI
TSSI
Annualised
TSSI
95.8%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
TSSI
TSSI
Revenue
$40.7M
$60.9M
Net Profit
$-10.6M
$12.2M
Gross Margin
23.3%
17.6%
Operating Margin
-25.7%
1.5%
Net Margin
-26.0%
20.0%
Revenue YoY
-23.3%
21.8%
Net Profit YoY
-1392.6%
535.7%
EPS (diluted)
$-0.50
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
TSSI
TSSI
Q4 25
$40.7M
$60.9M
Q3 25
$44.4M
$41.9M
Q2 25
$51.2M
$44.0M
Q1 25
$50.8M
$99.0M
Q4 24
$52.0M
$50.0M
Q3 24
$58.0M
$70.1M
Q2 24
$66.2M
$12.2M
Q1 24
$65.1M
$15.9M
Net Profit
PETS
PETS
TSSI
TSSI
Q4 25
$-10.6M
$12.2M
Q3 25
$-8.5M
$-1.5M
Q2 25
$-34.2M
$1.5M
Q1 25
$-11.6M
$3.0M
Q4 24
$-707.0K
$1.9M
Q3 24
$2.3M
$2.6M
Q2 24
$3.8M
$1.4M
Q1 24
$-5.0M
$15.0K
Gross Margin
PETS
PETS
TSSI
TSSI
Q4 25
23.3%
17.6%
Q3 25
28.0%
11.1%
Q2 25
28.1%
17.8%
Q1 25
29.9%
9.3%
Q4 24
31.0%
14.4%
Q3 24
32.3%
11.3%
Q2 24
28.8%
37.3%
Q1 24
29.3%
17.1%
Operating Margin
PETS
PETS
TSSI
TSSI
Q4 25
-25.7%
1.5%
Q3 25
-18.9%
-2.2%
Q2 25
-66.7%
5.1%
Q1 25
-11.9%
4.2%
Q4 24
-0.9%
0.0%
Q3 24
1.0%
5.4%
Q2 24
6.6%
14.0%
Q1 24
-5.9%
1.6%
Net Margin
PETS
PETS
TSSI
TSSI
Q4 25
-26.0%
20.0%
Q3 25
-19.2%
-3.6%
Q2 25
-66.7%
3.4%
Q1 25
-22.9%
3.0%
Q4 24
-1.4%
3.8%
Q3 24
4.0%
3.8%
Q2 24
5.7%
11.5%
Q1 24
-7.7%
0.1%
EPS (diluted)
PETS
PETS
TSSI
TSSI
Q4 25
$-0.50
$0.44
Q3 25
$-0.41
$-0.06
Q2 25
$-1.65
$0.06
Q1 25
$-0.56
$0.12
Q4 24
$-0.03
$0.08
Q3 24
$0.11
$0.10
Q2 24
$0.18
$0.06
Q1 24
$-0.24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
TSSI
TSSI
Cash + ST InvestmentsLiquidity on hand
$26.9M
$85.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$76.6M
Total Assets
$88.0M
$184.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
TSSI
TSSI
Q4 25
$26.9M
$85.5M
Q3 25
$36.1M
$70.7M
Q2 25
$41.1M
Q1 25
$54.7M
Q4 24
$50.1M
$23.2M
Q3 24
$52.0M
$46.4M
Q2 24
$46.0M
$8.3M
Q1 24
$55.3M
$14.4M
Stockholders' Equity
PETS
PETS
TSSI
TSSI
Q4 25
$32.8M
$76.6M
Q3 25
$43.1M
$63.4M
Q2 25
$51.5M
$9.5M
Q1 25
$85.1M
$9.4M
Q4 24
$96.2M
$7.1M
Q3 24
$96.4M
$7.7M
Q2 24
$93.5M
$5.2M
Q1 24
$96.7M
$3.7M
Total Assets
PETS
PETS
TSSI
TSSI
Q4 25
$88.0M
$184.9M
Q3 25
$100.3M
$165.4M
Q2 25
$109.8M
$139.5M
Q1 25
$148.7M
$113.5M
Q4 24
$144.8M
$96.6M
Q3 24
$146.0M
$67.3M
Q2 24
$152.7M
$28.9M
Q1 24
$169.9M
$26.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
TSSI
TSSI
Operating Cash FlowLast quarter
$-9.2M
$16.3M
Free Cash FlowOCF − Capex
$-9.2M
$15.8M
FCF MarginFCF / Revenue
-22.7%
25.9%
Capex IntensityCapex / Revenue
0.1%
0.9%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
TSSI
TSSI
Q4 25
$-9.2M
$16.3M
Q3 25
$-2.2M
$-18.4M
Q2 25
$-12.3M
$16.3M
Q1 25
$7.0M
$20.6M
Q4 24
$-1.2M
$-21.6M
Q3 24
$7.4M
$38.6M
Q2 24
$-8.5M
$-4.3M
Q1 24
$7.1M
$2.6M
Free Cash Flow
PETS
PETS
TSSI
TSSI
Q4 25
$-9.2M
$15.8M
Q3 25
$-4.8M
$-24.9M
Q2 25
$-13.6M
$5.4M
Q1 25
$4.6M
$5.8M
Q4 24
$-1.9M
$-28.4M
Q3 24
$6.1M
$38.6M
Q2 24
$-9.2M
$-6.0M
Q1 24
$5.9M
$2.6M
FCF Margin
PETS
PETS
TSSI
TSSI
Q4 25
-22.7%
25.9%
Q3 25
-10.8%
-59.3%
Q2 25
-26.5%
12.3%
Q1 25
9.1%
5.8%
Q4 24
-3.7%
-56.7%
Q3 24
10.6%
55.1%
Q2 24
-13.9%
-49.4%
Q1 24
9.0%
16.4%
Capex Intensity
PETS
PETS
TSSI
TSSI
Q4 25
0.1%
0.9%
Q3 25
5.9%
15.3%
Q2 25
2.5%
24.8%
Q1 25
4.7%
15.0%
Q4 24
1.5%
13.4%
Q3 24
2.2%
0.1%
Q2 24
1.0%
13.8%
Q1 24
1.9%
0.2%
Cash Conversion
PETS
PETS
TSSI
TSSI
Q4 25
1.34×
Q3 25
Q2 25
11.02×
Q1 25
6.93×
Q4 24
-11.32×
Q3 24
3.18×
14.60×
Q2 24
-2.27×
-3.09×
Q1 24
176.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

TSSI
TSSI

Procurement Revenues Segment$43.2M71%
System Integration Services Segment$14.2M23%
Facilities Segment$3.5M6%

Related Comparisons